{"id":33273,"date":"2018-02-14T12:00:00","date_gmt":"2018-02-14T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/"},"modified":"2018-02-14T12:00:00","modified_gmt":"2018-02-14T12:00:00","slug":"immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/","title":{"rendered":"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1493 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Bruxelles 2017<\/h2>\n<p>Les experts recommandent que les enfants \u00e2g\u00e9s de cinq ans re\u00e7oivent une AIT s\u2019ils pr\u00e9sentent une pr\u00e9disposition familiale. Ces enfants constituent la population cible id\u00e9ale pour l\u2019AIT. Les candidats id\u00e9aux sont ceux qui souffrent de rhinite allergique sans asthme, mais avec certains signes indiquant que la rhinite allergique est susceptible de s\u2019\u00e9tendre aux voies respiratoires inf\u00e9rieures. Ces signes peuvent \u00eatre une hyperr\u00e9activit\u00e9 bronchique, le fait qu\u2019ils sifflent lors de rhumes, ou encore une \u00e9l\u00e9vation de leur Eno pendant la saison du rhume des foins.   <\/p>\n<p>Les interviews ont \u00e9t\u00e9 enregistr\u00e9es lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1494 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/G1VWFi6Lq84?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Bruxelles 2017 Les experts recommandent que les enfants \u00e2g\u00e9s de cinq ans re\u00e7oivent une AIT s\u2019ils pr\u00e9sentent une pr\u00e9disposition familiale. Ces enfants constituent la population cible id\u00e9ale pour l\u2019AIT. Les candidats id\u00e9aux sont ceux qui souffrent de rhinite allergique sans asthme, mais avec certains signes indiquant que la rhinite allergique est susceptible de s\u2019\u00e9tendre aux voies respiratoires inf\u00e9rieures. Ces signes peuvent \u00eatre une hyperr\u00e9activit\u00e9 bronchique, le fait qu\u2019ils sifflent lors de rhumes, ou encore une \u00e9l\u00e9vation de leur Eno pendant la saison du rhume des foins. Les interviews ont \u00e9t\u00e9 enregistr\u00e9es lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.<\/p>\n","protected":false},"author":1,"featured_media":33288,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[189],"tags":[190,191,192,248,170,172],"class_list":["post-33273","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-rhinologie","tag-debats","tag-rhinology-future-debates","tag-immunotherapie-allergenique-ita","tag-professionnels-de-sante","tag-asthme"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Bruxelles 2017 Les experts recommandent que les enfants \u00e2g\u00e9s de cinq ans re\u00e7oivent une AIT s\u2019ils pr\u00e9sentent une pr\u00e9disposition familiale. Ces enfants constituent la population cible id\u00e9ale pour l\u2019AIT. Les candidats id\u00e9aux sont ceux qui souffrent de rhinite allergique sans asthme, mais avec certains signes indiquant que la rhinite allergique est susceptible de s\u2019\u00e9tendre aux voies respiratoires inf\u00e9rieures. Ces signes peuvent \u00eatre une hyperr\u00e9activit\u00e9 bronchique, le fait qu\u2019ils sifflent lors de rhumes, ou encore une \u00e9l\u00e9vation de leur Eno pendant la saison du rhume des foins. Les interviews ont \u00e9t\u00e9 enregistr\u00e9es lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/\",\"name\":\"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_Challenges20for20the20prevention20of20asthma.png\",\"datePublished\":\"2018-02-14T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_Challenges20for20the20prevention20of20asthma.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Allergen20immunotherapy_Challenges20for20the20prevention20of20asthma.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/","og_locale":"fr_FR","og_type":"article","og_title":"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme","og_description":"Rhinology Future Debates Bruxelles 2017 Les experts recommandent que les enfants \u00e2g\u00e9s de cinq ans re\u00e7oivent une AIT s\u2019ils pr\u00e9sentent une pr\u00e9disposition familiale. Ces enfants constituent la population cible id\u00e9ale pour l\u2019AIT. Les candidats id\u00e9aux sont ceux qui souffrent de rhinite allergique sans asthme, mais avec certains signes indiquant que la rhinite allergique est susceptible de s\u2019\u00e9tendre aux voies respiratoires inf\u00e9rieures. Ces signes peuvent \u00eatre une hyperr\u00e9activit\u00e9 bronchique, le fait qu\u2019ils sifflent lors de rhumes, ou encore une \u00e9l\u00e9vation de leur Eno pendant la saison du rhume des foins. Les interviews ont \u00e9t\u00e9 enregistr\u00e9es lors des Rhinology Future Debates Bruxelles 2017 avec Oliver Pfaar, David Price et Glenis Scadding.","og_url":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/","url":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/","name":"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_Challenges20for20the20prevention20of20asthma.png","datePublished":"2018-02-14T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_Challenges20for20the20prevention20of20asthma.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Allergen20immunotherapy_Challenges20for20the20prevention20of20asthma.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/immunotherapie-allergenique-defis-pour-la-prevention-de-lasthme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"Immunoth\u00e9rapie allerg\u00e9nique : d\u00e9fis pour la pr\u00e9vention de l\u2019asthme"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/33273","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=33273"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/33273\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/33288"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=33273"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=33273"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=33273"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}